Ruixia Jiang

Title: Ruixia Jiang: Innovator in Non-Steroidal Anti-Inflammatory Medicaments

Introduction

Ruixia Jiang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of non-steroidal anti-inflammatory medicaments. His innovative work has the potential to improve the treatment of various medical conditions.

Latest Patents

Ruixia Jiang holds a patent for "Aryl (ethanoic) propanoic acid ascorbyl ester, preparation method thereof and medicament containing the same." This invention focuses on designing and synthesizing ascorbyl ester derivatives of aryl (ethanoic) propanoic acid non-steroidal anti-inflammatory medicaments, such as ibuprofen, ketoprofen, and naproxen. The medicament demonstrates remarkable antipyretic and analgesic effects, making it suitable for a wide range of patients, including the elderly, infants, and children. The invention enhances water solubility, facilitates intravenous administration, and improves bioavailability while reducing gastrointestinal stimulation.

Career Highlights

Throughout his career, Ruixia Jiang has worked with Wuxi Hongrui Bio-Pharma-Tech Co., Ltd. His expertise in pharmaceutical development has led to advancements in the treatment of conditions such as arthritis, dysmenorrhea, multiple sclerosis, and certain cancers.

Collaborations

Ruixia Jiang has collaborated with notable colleagues, including Luhong Tang and Ajuan Dai. These partnerships have contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Ruixia Jiang's contributions to the field of non-steroidal anti-inflammatory medicaments highlight his role as a significant inventor. His work not only addresses critical medical needs but also paves the way for future innovations in pharmaceutical treatments.